Market Update Economic Events Directors Deals Commodities Prices News Market Movers

Angle collaborates with Abbott for cancer analysis research

Tuesday, 6th February 2018
Liquid biopsy company Angle said it had agreed to source probe kits from global healthcare group Abbott to assist in its cancer analysis research.

'This is another important collaboration for Angle with a leader in downstream analysis,' Angle chief executive Andrew Newland said.

'Abbott's PathVysion is the market leader for FISH evaluation of HER-2 in breast cancer. Following our FDA studies, we hope to be able to work with Abbott to extend PathVysion use into routine blood test analysis as an important downstream application of the Parsortix system in breast cancer.'

At 1:56pm: (LON:AGL) Angle PLC share price was -1.5p at 44.5p

Story provided by

Related Shares: Angle

Share Search
Share Search Share Search

Visit the Share Search.
Share Search

Share News
Share News will do their best to ensure the quality of the information displayed on this site, but all information is provided as-is, free of charge. We cannot be held responsible for any loss, material or otherwise, due to incorrect information found here. UK data supplied by NBTrader and Digital Look. Share Prices are at least 15 minutes delayed.